A first diagnosis of multiple sclerosis can come between the wide age range of 15 to 50. Celebrities Jamie-Lynn Sigler, Jack Osborne, and Trevor Bayne all have MS and chances are you may know someone that is afflicted is well. When it comes to treating multiple sclerosis, the latest news is positive and these MS developments are giving the recently diagnosed hopeful prospects for their future.
Before diving into multiple sclerosis and the latest research victories, it is important to understand the disease. This neurological disorder impacts nerve fibers in the brain and spinal cord. The two forms of MS are relapsing, including Relapsing-remitting MS (or RRMS) and progressive MS, which includes MS Secondary-progressive MS (SPMS), MS Primary-progressive (PPMS) and Progressive relapsing (PRMS).
Relapsing MS is defined as having a clearly defined worsening of neurological functioning, followed by periods of remission where there is no apparent worsening of the disease. The progressive forms of MS differ when it comes to worsening of the disease, in this form it happens steadily relapse or not. A life of flare ups and degenerating functionality can clearly be scary for anyone diagnosed with the disease, but it doesn’t mean life is over.
New Treatments On the Horizon
Ocrelizumab is an exciting new multiple sclerosis drug treatment currently making its way through the FDA approval process. Expected as soon as 2017, this drug works on both relapsing and progressive MS. This is especially important because relapsing MS often leads to progressive MS over the years.
MS researchers are hopeful that they can make additional headway in the actual cause of the disease, as preliminary results of this drug use show a connection between the inflammation in relapsing MS and the eventual onset of progressive MS. Researchers hope that with early onset treatment for relapsing MS using ocrelizumab, the disease won’t advance to the progressive stage.
This drug isn’t the only advancement being made in treating multiple sclerosis. Latest research from The University of Cambridge examines the viability of Vitamin D as a potential MS therapy. The protective sheath myelin is meant to protect nerve fibers. Everyone sees a decline in their ability to repair myelin as they age, but having MS will damage the myelin directly. In preliminary research, university scientists are finding that Vitamin D spurs the creation of new myelin making cells by 80% when added to a specific protein during laboratory experiments.
This research is still very much in infancy while scientists work to understand the biology involved, but hope is on the horizon. Fortunately, vitamin D is a compound humans are known to need so addressing the topic with one’s physician to ensure there isn’t a vitamin deficiency could have hidden benefits for healthy and MS sufferers alike.
Griswold Home Care has a unique understand of MS, as founder Jean Griswold was first diagnosed with multiple sclerosis at the age of 39. It led to her requiring the use of a wheelchair, but didn’t stop her from achieve great things, like founding her namesake senior home care organization. When it comes to resources on multiple sclerosis, latest treatment options, info on the psychosocial barriers of MS, care options and much more can be found in Griswold’s guide to multiple sclerosis.